have revealed that glucagon-like peptide-1 (GLP-1) has a highly significant positive effect on patients with diabetes and multiple myeloma.
← all excerpts
Global, regional, and national metabolic risk factors associated with multiple myeloma, 1990-2021: analysis via the global burden of disease study 2021.
1
—
—